Reuters logo
3 years ago
BRIEF-Erytech reports additional positive phase III results for ERY-ASP/GRASPA
December 8, 2014 / 7:43 AM / 3 years ago

BRIEF-Erytech reports additional positive phase III results for ERY-ASP/GRASPA

Dec 8 (Reuters) - Erytech Pharma SA :

* Reports additional positive phase III results from clinical study with ERY-ASP/GRASPA in Acute Lymphoblastic Leukemia

* Study was not powered to demonstrate statistical significance on any of secondary parameters

* "Results will support plans for regulatory filing of GRASPA in European Union in first half of 2015 and accelerating development in United States" - CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below